BamSEC and AlphaSense Join Forces
Learn More

Moleculin Biotech Inc. – Material Contracts

NASDAQ: MBRX    
Share price (8/5/26): $0.39    
Market cap (8/5/26): $7.596 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.35
from S-1 3 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 10 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 5 pages Holder of Common Stock Purchase Warrants Re: Offer to Amend Common Stock Purchase Warrants the Holder Hereby Agrees to Amend the Existing Warrants as Follows And, in Consideration for Such Amendments, the Company Also Agrees to the Following
12/34/56
EX-10.2
from 8-K 10 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 10 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 8 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.35
from S-1/A 39 pages Securities Purchase Agreement
12/34/56
EX-10.35
from S-1/A 39 pages Securities Purchase Agreement
12/34/56
EX-10.35
from S-1 39 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 13 pages Placement Agency Agreement
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 6 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.34
from S-1/A 39 pages Securities Purchase Agreement
12/34/56
EX-10.35
from S-1/A 3 pages This Waiver (This “Waiver”) Is Entered Into by and Among Moleculin Biotech, Inc., a Delaware Corporation (The “Company”), and the Purchaser Signatory Hereto (The “Purchaser”). Reference Is Hereby Made to That Certain Securities Purchase Agreement, Dated as of August 15, 2024, by and Between the Company and the Purchaser (The “Purchase Agreement”). Capitalized Terms Used Herein That Are Not Otherwise Defined Shall Have the Meaning Ascribed Thereto in the Purchase Agreement
12/34/56
EX-10.34
from S-1/A 39 pages Securities Purchase Agreement
12/34/56
EX-10.34
from S-1/A 39 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 12 pages Moleculin Biotech, Inc. 2024 Stock Plan
12/34/56
EX-10.2
from 8-K 1 page Re: Amendment to Existing Warrants Dear Holder
12/34/56